FTO and neoplasm: Analogs of α-ketoglutarate (α-KG) represent another class of FTO inhibitors with potential application as anti-tumor drugs; these compounds compete with α-KG by chelating iron within the FTO active site, thereby inhibiting its catalytic function (Su et al. 2018).